https://go.evvnt.com/1071570-0?pid=5248 The Bostonian Boston
26 North Street
Boston, Massachusetts 02109
$Drug Developer Pricing - Conference + 2 Workshops USD 4297.00 Drug Developer Pricing - Conference + 1 Workshop USD 3648.00 Drug Developer Pricing - Conference Only USD 2999.00 Academic Research Institute Pricing - Conference + 2 Workshops USD 3697.00 Academic Research Institute Pricing - Conference + 1 Workshop USD 3148.00 Academic Research Institute Pricing - Conference Only USD 2599.00 Standard Pricing - Conference + 2 Workshops USD 5097.00 Standard Pricing - Conference + 1 Workshop USD 4348.00 Standard Pricing - Conference Only USD 3599.00
Lectures & Conferences
Built with biopharmaceutical industry insights, this in-person conference will delve into the latest advancements of non-viral RNA delivery systems such as LNPs, exosomes and polymers to set the scene for the translation of targeted, safe and durable delivery systems for RNA therapeutics and vaccines with improved formulation, distribution and tissue-specificity.
Don't miss 20+ pioneering speakers from large pharma, innovative biotech, and KOLs of academia who are shaping the landscape of advanced and emerging non-viral RNA delivery systems for the RNA biopharma community worldwide.
Join this meeting to hear cutting-edge science and latest data on:
Expand Therapeutic Applications with Emerging Non-Viral RNA Delivery Systems
Discover Novel LNP & Alternative Technologies to Increase Specificity & Efficacy
Learn About the Latest Improvements of Non-Viral Delivery Systems for the Delivery of a Broad Range of RNA Payloads
Increase Tissue Specific & Extrahepatic Delivery through Optimizing Formulation & Design
Delve into the emerging Engineering, Formulation & Packaging Methods to Improve Non- Viral RNA Delivery & Stability
Join 80+, VPs, Heads and Directors of RNA delivery, Formulation and Process development for a deep dive into delivery challenges and strategies of non-viral systems to fully unleash the therapeutic opportunities offered by different RNA therapeutics and vaccines.
Speakers: Heinrich Haas, Vice President Formulation & Drug Delivery, BioNTech, Larry Brown, Research & Development, Executive Vice President & Chief Scientific Officer, Noveome Biotherapeutics, Shawn Davis, Executive Director, Drug Delivery, AstraZeneca, Patrick Baumhof, Senior Vice President of Technology, CureVac, Hamideh Parhiz, Research Assistant, Professor of Medicine, University of Pennsylvania, Xiaoyong Lu, Director of Chemistry & Oligonucleotide Delivery, Sirnaomics, Mohamed ElSayed, Senior Research Fellow, Eli Lilly & Company, Olga Villamizar, Scientist, Ultragenyx, AJ Bergman, Chief Executive Officer, Capricor Therapeutics, Alena Ivanova, Postdoctoral Fellow, AstraZeneca, Ashish Sarode, Principal Scientist, Delivery & Formulation, Sanofi, Benjamin Bleier, Associate Professor & Director of Translational Research; Director of Endoscopic Skull Base Surgery & Director (Co) of Center for Orbital Surgery & Claire and John Bertucci Chair in OHNS, Harvard Medical School, Bulent Ozpolat, Associate Professor, MD Anderson Cancer Center, Curtis Dobrowolski, Co-Founder, LNPnewCo, Daniel Anderson, Professor, MIT, Jay Sarkar, Visiting Scholar, Stanford University, John Lewis, Chief Executive Officer, Entos Pharmaceuticals, Mansoor Amiji, Professor of Pharmaceutical Sciences, & Professor of Chemical Engineering, Northeastern University, Nelly Valkov, Scientist II, Vesigen Therapeutics, Poulami Talukder, Senior Scientist, Tiba Biotech, Shayak Samaddar, Research Scientist, Eli Lilly, Tatiana Bronich, Professor, Northeastern University